HPC Stock Overview
The Hydration Pharmaceuticals Company Limited markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, the Unites States, and Canada. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
The Hydration Pharmaceuticals Company Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.017 |
52 Week High | AU$0.032 |
52 Week Low | AU$0.008 |
Beta | 1.3 |
11 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | -50.00% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -94.93% |
Recent News & Updates
Recent updates
Shareholder Returns
HPC | AU Personal Products | AU Market | |
---|---|---|---|
7D | 0% | -7.6% | 0.9% |
1Y | -50.0% | 51.8% | 18.4% |
Return vs Industry: HPC underperformed the Australian Personal Products industry which returned 51.8% over the past year.
Return vs Market: HPC underperformed the Australian Market which returned 18.4% over the past year.
Price Volatility
HPC volatility | |
---|---|
HPC Average Weekly Movement | n/a |
Personal Products Industry Average Movement | 5.6% |
Market Average Movement | 8.5% |
10% most volatile stocks in AU Market | 17.5% |
10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: HPC's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: Insufficient data to determine HPC's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | n/a | Oliver Baker | www.hydralyte.com |
The Hydration Pharmaceuticals Company Limited markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, the Unites States, and Canada. It sells its products under the Hydralyte brand name through retail stores and e-commerce channels. The Hydration Pharmaceuticals Company Limited was founded in 2001 and is headquartered in Melbourne, Australia.
The Hydration Pharmaceuticals Company Limited Fundamentals Summary
HPC fundamental statistics | |
---|---|
Market cap | AU$5.18m |
Earnings (TTM) | -AU$11.81m |
Revenue (TTM) | AU$14.92m |
0.3x
P/S Ratio-0.4x
P/E RatioIs HPC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HPC income statement (TTM) | |
---|---|
Revenue | US$9.70m |
Cost of Revenue | US$4.27m |
Gross Profit | US$5.43m |
Other Expenses | US$13.12m |
Earnings | -US$7.68m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.025 |
Gross Margin | 56.00% |
Net Profit Margin | -79.18% |
Debt/Equity Ratio | -170.3% |
How did HPC perform over the long term?
See historical performance and comparison